4//SEC Filing
Kelly Lisa 4
Accession 0001209191-12-053796
CIK 0000875320other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:35 PM ET
Size
11.2 KB
Accession
0001209191-12-053796
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Sale
Common Stock
2012-11-15$40.59/sh−355$14,409→ 17,249 total - Sale
Common Stock
2012-11-16$41.28/sh−2,033$83,922→ 15,216 total
Holdings
- 1,959(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $40.59 (range $40.34 to $41.23).
- [F3]Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $41.28 (range $41.01 to $41.82).
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001349077
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:35 PM ET
- Size
- 11.2 KB